What is the current state of research on long-term therapy using PARP inhibitors in patients with BRCA mutations?
Hassan GHAZAL
oncologist, Dubai
oncologist, Dubai
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Didier Bourgeois
Chirurgien cancérologue spécialisé en sénologie et gynécologie
à l’Institut du Sein Henri Hartmann, Neuilly Sur Seine, France
Copyright © 2026 - BCU